Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
93,842,572
-
Share change
-
+3,050,414
-
Total reported value
-
$2,001,184,734
-
Put/Call ratio
-
5.1%
-
Price per share
-
$21.32
-
Number of holders
-
185
-
Value change
-
+$66,089,493
-
Number of buys
-
91
-
Number of sells
-
88
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2024
As of 31 Mar 2024,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
185 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,842,572 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Camber Capital Management LP, STATE STREET CORP, GLENVIEW CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, EARNEST PARTNERS LLC, DIMENSIONAL FUND ADVISORS LP, and BANK OF AMERICA CORP /DE/.
This page lists
185
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.